What are you searching for?

01.08.2021 | Tracker

HCPs discuss “booster shot” to decrease the high spread of the Delta variant.

By CREATION.co

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

 

July
Rank
June
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer36,5251,70068
22AstraZeneca11,18244113
33Johnson & Johnson5,51744673
44Biogen1,3766990
55GSK65620628
68Roche42915834
712Bayer38213225
87Gilead367888
910Sanofi36612429
106Novartis31122316
1114Abbott29226222
1213Merck & Co27015973
1317Boehringer Ingelheim23219535
1411Novo Nordisk19517233
159Regeneron188868
1620Otsuka16971
1715Lilly1689318
1822Amgen101675
1919AbbVie90629
2021Fresenius744018
2126Teva685929
2225Takeda645810
2316BMS59533
2427Merck KGaA585819
2524Eisai47212
2618Mylan4300
2729CSL413611
2836Allergan3910
2930Chugai3920
3034Astellas36260
3140Sun342718
3223UCB242216
3335Bausch23110
3432Ipsen17117
3528Servier1684
3637Menarini15128
3739Grifols1400
3831Alexion1371
3933Daiichi Sankyo1242
4038Vertex980
4150Mitsubishi Tanabe Pharma550
4247Aurobindo100
4346Endo100
4448Ono100
5045Jiangsu Hengrui000
5044Meiji000
5043Shanghai000
5049Sino000
5041Sumitomo Dainippon000
5042Yunnan Baiyao000

 

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

In the month of July, the top five pharmaceutical companies mentioned by healthcare professionals (HCPs) remained the same and were positioned in the same ranking. Pfizer was located first, followed by AstraZeneca, Johnson and Jhonson (J&J), Biogen, and GSK.

Top 5 pharma companies mentioned by HCPs in Dec 2020

Compared to last month, the HCP conversation increased by two percent. The slight increase was seen due to the continuation of HCP discussion about the efficacy of COVID-19 vaccines against the Delta, Alpha, Beta, and Lambda variants. Many HCPs shared data showing the percentage of effectiveness that different vaccines have against these variants, and some showed concern about the high spread of the Delta variant among people that are vaccinated.

HCPs also shared the news of Pfizer seeking an FDA approval for a “booster shot” after two doses of their vaccine, since there is data showing that the antibody levels decrease after 6 months of being vaccinated. This aim is to prevent the continued spread of the Delta variant, yet some HCPs say that the data is not compelling enough to justify the approval.

Another topic of the HCP conversation was the vaccine roll-out that various governments are undertaking. Some HCPs criticized governments for not giving enough vaccines to the people.

The three most shared links by HCPs in July were:

  1. An article published by NEJM showing the effectiveness of COVID-19 vaccines against the Delta variant.
  2. A news article from The Times of Israel showing that the Health Ministry of Israel said that even though the Pfizer vaccine is only 64% effective against the Delta variant, it is still effective at preventing serious symptoms and hospitalizations.
  3. An article from Medrxiv showing a study of the safety and efficacy of the Pfizer vaccine after six months of administration.

Top 50 pharma companies mentioned by HCPs in July 2021

The volume of HCP COVID-19 conversation in the context of top 50 pharma increased by about 800 posts from June to July, making up 65% of the overall HCP conversation in July.

Outside the COVID-19 conversation, HCPs discussed a variety of different topics from different therapy areas. J&J was mentioned due to the recalling of the Neutrogena and Aveeno spray sunscreens that were found to have low levels of benzene, a chemical known for causing cancer, in some of their samples. Boehringer was mentioned by HCPs discussing the EMPEROR-Preserve trial results showing Jardiance (empagliflozin) as efficient for treating heart failure with preserved ejection fraction (HFpEF).

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

  • In July 2021, CREATION Pinpoint® identified 53,055 healthcare professional (HCP) authored tweets from 15,336 individual HCPs mentioning a Top 50 pharmaceutical company (according to revenue).
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 pharmaceutical company between July 1st and July 31st 2021.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (eg. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In July, 2,186 of these posts mentioned Janssen.

View all articles >

Meet the Author

CREATION.co

Suggested next


25.11.2020 | Whitepaper

White Paper: 10 questions to ask about your Digital Opinion Leaders

HCP ‘Digital Opinion Leaders’ (DOLs) are driving health policy decisions

24.03.2020 | Article

Webinar: Coronavirus digital communication strategies for NGOs, Government and Health Policy

Webinar: Coronavirus digital communication strategies for NGOs, Government and Health Policy

By Luke Wilson

View all articles >